Adaptive Biotechnologies Investor Relations Material
Latest events
Status Update
Adaptive Biotechnologies
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Adaptive Biotechnologies Corporation
Access all reports
Segment Data
Access more data
Revenue by
Business area
Immune Medicine
Minimal Residual Disease
Expenses by
Financials
Adaptive Biotechnologies Corporation operates as a commercial-stage biotechnology company. It provides immunosequencing and immunodiagnostic solutions. Furthermore the company offers research and development, and customer-focused services primarily to academic, government, pharmaceutical, biotechnology, hospital/clinical laboratories, and other companies in the United States and internationally. It operates in two segments, Adaptive Diagnostics and Adaptive Therapeutics. The company's immune system platform analyzes and interprets T cell and B cell receptor sequencing data.
Key slides for Adaptive Biotechnologies Corporation
Q4 2023
Adaptive Biotechnologies Corporation
Investor Presentation
Adaptive Biotechnologies Corporation
Latest articles
Four Decades of IPOs: An Overview
An overview of the stock and IPO market from the 80's until today, highlighting important events and trends.
24 Apr 2024
Larry Page: The Mastermind Behind Google
Explore the journey of Larry Page from a tech-savvy youth to co-founding Google and leading Alphabet.
24 Apr 2024
Mark Leonard: The Mysterious Brain Behind Constellation Software
Information about Mark Leonard is scarce, and one of the only ways to “get to know” him is through his shareholder letters. Join us in an attempt to do so.
24 Apr 2024
Ticker symbol
Country
🇺🇸 United States